14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent Bitcoin price jumps.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ayrshire Capital Management John Nevin Jr. | 8,592 | $6,697,981 | +10% | 3.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | $199,548.64 | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | $49,849.56 | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | $99,912.54 | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | $149,846.80 | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | $108,840.00 | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $716.41 | 1,000 | $716,410.00 | 4,840 | 2025-05-27 | Filing | |
| $749.24 | 1,250 | $936,550.00 | 27,510 | 2025-05-14 | Filing | |
| $818.24 | 1,000 | $818,240.00 | 5,840 | 2025-03-13 | Filing | |
| $934.89 | 812 | $759,129.87 | 96,016,978 | 2025-03-03 | Filing | |
| $933.74 | 3,997 | $3,732,138.80 | 96,017,790 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 96,016,978 | $74,848,114,860 | 100% | |
| 2. | 1,481,031 | $1,154,508,095 | 1.71% | |
| 3. | 1,321,929 | $1,030,483,311 | 1.16% | |
| 4. | 1,218,487 | $949,847,047 | 17.01% | |
| 5. | 557,659 | $434,711,942 | 23.82% |
News See All
Eli Lilly (LLY) Announced Results for its Once-Weekly Insulin
Eli Lilly and Company (NYSE:LLY) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On June 22, Eli Lilly and Company (NYSE:LLY) announced new results for its once-weekly insulin, Efsitora...
10 Best Non-Tech Stocks to Buy and Hold For 3 Years
On July 4, Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t hurt the economy.
UBS Sees Strong Sales Outlook for Eli Lilly’s Zepbound and Mounjaro
Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy.
Eli Lilly (LLY) Staring at Tremendous Opportunity in Alzheimer Market: RBC Capital Markets
Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts.
13 Best Blue Chip Stocks to Buy According to Analysts
The US equity market has recorded a stunning recovery after President Donald Trump's tariff policies sent markets on a tailspin in April.
15 Set-It-and-Forget-It Stocks to Buy According to Analysts
As expectations for trade agreements and potential rate cuts reduced investor anxiety, the S&P 500 and Nasdaq reached record closing highs on June 30, concluding their strongest quarter in over a year...
FDA Approves Updated Label For Eli Lilly and Company (LLY)'s Amyvid To Support Alzheimer’s Diagnosis
Eli Lilly and Company (NYSE:LLY) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy.
Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy
The S&P 500 rose by 0.52% on Friday to close at a record high of 6,173.07, marking returns of 3.44% for the week, as traders looked past the termination of trade talks between the United States and Canada...
Truist Reiterates Eli Lilly (LLY) Buy Rating on Orforglipron Diabetes Drug Data
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities reiterated its “Buy” rating on Eli Lilly stock.
Billionaire Hedge Funds
